News

In a reversal of its earlier stance, AstraZeneca has confirmed a £300m commitment to the UK, marking a renewed push into domestic operations after previously halting major projects. The announcement, delivered in Parliament by Keir Starmer, signals a shift...

The landscape of regenerative medicine has shifted significantly toward signaling molecules that can modulate gene expression. Among the most researched and versatile of these molecules is the GHK-Cu peptide, a naturally occurring copper complex first identified in human plasma. As...

Sun Pharmaceutical Industries has agreed to acquire Organon in a transaction valued at $11.75 billion, creating what the company described as the largest Biopharma Deal recorded in 2026. The agreement brings together two businesses that each generated $6.2 billion...

Healthcare systems can collapse overnight, particularly in natural disasters and conflicts that force communities to flee. In such moments, speed matters as much as skill. People need treatment for injuries, infections, childbirth complications, and chronic illnesses long before permanent...

This article includes: Expanding the Role of Mail-Order Pharmacies Overcoming Operational Hurdles With Error-Reduction Systems Examining the Key Pillars of Pharmacy Automation Transformation Capsa Healthcare: A Blueprint for Automated Success Frequently Asked Questions About Pharmacy Automation Automating Solutions for...

The US Food and Drug Administration has awarded three additional Commissioner's National Priority Vouchers under its accelerated regulatory framework, targeting companies developing psychedelic-based therapies. The move follows President Donald Trump’s April 18 executive order aimed at advancing mental health...

MSD has entered into a multi-year agreement with Google Cloud valued at up to $1 billion, enabling widespread deployment of advanced artificial intelligence tools across its global workforce of 75,000 employees. The collaboration will integrate Google Cloud’s agentic AI...